[Federal Register Volume 62, Number 115 (Monday, June 16, 1997)]
[Notices]
[Page 32617]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-15636]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Request for Nominations for Members on Public Advisory 
Committees; Veterinary Medicine Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for members to serve on the Veterinary Medicine Advisory 
Committee (the committee) in FDA's Center for Veterinary Medicine.
    FDA has a special interest in ensuring that women, minority groups, 
and individuals with disabilities are adequately represented on 
advisory committees and, therefore, the agency encourages nominations 
of appropriately qualified candidates from these groups.

DATES: No cutoff date is established for receipt of nominations.

ADDRESSES: All nominations for membership should be sent to Jacquelyn 
L. Pace (address below).

FOR FURTHER INFORMATION CONTACT: Jacquelyn L. Pace, Center for 
Veterinary Medicine (HFV-200), Food and Drug Administration, 7500 
Standish Pl., Rockville, MD 20855, 301-594-5920.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for members to 
serve on the committee. The function of the committee is to review and 
evaluate available data concerning safety and effectiveness of marketed 
and investigational new animal drugs, feeds, and devices for use in the 
treatment and prevention of animal disease and increased animal 
production.

Criteria for Members

    Persons nominated for membership on the committee shall have 
adequately diversified experience that is appropriate to the work of 
the committee in such fields as companion animal medicine, food animal 
medicine, avian medicine, microbiology, biometrics, toxicology, 
pathology, pharmacology, animal science, epidemiology and chemistry.
    The specialized training and experience necessary to qualify the 
nominee as experts suitable for appointment are subject to review, but 
may include experience in medical practice, teaching, and/or research 
relevant to the field of activity of the committee. The term of office 
is 4 years.

Nomination Procedures

    Any interested person may nominate one or more qualified persons 
for membership on the committee. Nominations shall state that the 
nominee is aware of the nomination, is willing to serve as a member of 
the committee, and appears to have no conflict of interest that would 
preclude committee membership. A current copy of nominee's curriculum 
vitae should be included. Potential candidates will be asked by FDA to 
provide detailed information concerning such matters as employment, 
financial holdings, consultancies, and research grants or contracts in 
order to permit evaluation of possible sources of conflict of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14 relating to advisory committees.


    Dated: June 9, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-15636 Filed 6-13-97; 8:45 am]
BILLING CODE 4160-01-F